Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/19093199/ below:

Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia

Affiliations

• ¹ Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC 27710, USA. z.gellad@duke.edu

• PMID: 19093199
• PMCID: PMC3726721
• DOI: 10.1007/s10620-008-0653-8

Item in Clipboard

Ziad F Gellad et al. Dig Dis Sci. 2009 Nov.

• ¹ Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC 27710, USA. z.gellad@duke.edu

• PMID: 19093199
• PMCID: PMC3726721
• DOI: 10.1007/s10620-008-0653-8

Item in Clipboard

There is no guideline defining the optimal time from a positive screening fecal occult blood test to follow-up colonoscopy. We reviewed records of 231 consecutive primary care patients who received a colonoscopy within 18 months of a positive fecal occult blood test. We examined the relationship between time to colonoscopy and risk of neoplasia on colonoscopy using a logistic regression analysis adjusting for potential confounders such as age, race, and gender. The mean time to colonoscopy was 236 days. Longer time to colonoscopy (OR = 1.10, P = 0.01) and older age (OR 1.04, P = 0.01) were associated with higher odds of neoplasia. The association of time with advanced neoplasia was positive, but not statistically significant (OR 1.07, P = 0.14). In this study, a longer interval to colonoscopy after fecal occult blood test was associated with an increased risk of neoplasia. Determining the optimal interval for follow-up is desirable and will require larger studies.

PubMed Disclaimer

The authors have no relevant conflicts of interest to disclose.

• Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.

  Auge JM, Pellise M, Escudero JM, Hernandez C, Andreu M, Grau J, Buron A, López-Cerón M, Bessa X, Serradesanferm A, Piracés M, Macià F, Guayta R, Filella X, Molina R, Jimenez W, Castells A; PROCOLON Group. Auge JM, et al. Gastroenterology. 2014 Sep;147(3):628-636.e1. doi: 10.1053/j.gastro.2014.06.008. Epub 2014 Jun 14. Gastroenterology. 2014. PMID: 24937264

• Colon polyps and cancer.

  Kronborg O. Kronborg O. Endoscopy. 2002 Jan;34(1):69-72. doi: 10.1055/s-2002-19393. Endoscopy. 2002. PMID: 11778132 Review.

• Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.

  Partin MR, Burgess DJ, Burgess JF Jr, Gravely A, Haggstrom D, Lillie SE, Nugent S, Powell AA, Shaukat A, Walter LC, Nelson DB. Partin MR, et al. Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):422-34. doi: 10.1158/1055-9965.EPI-14-1170. Epub 2014 Dec 3. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25471345 Free PMC article.

• Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

  Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium. Chubak J, et al. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26843520 Free PMC article.

1. 1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
2. 1. Kronborg O, Fenger C, Jorn O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471. - PubMed
3. 1. Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371. - PubMed
4. 1. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ. 1998;317:559–565. - PMC - PubMed
5. 1. Bond JH. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective. Am J Gastroenterol. 2006;101:219–221. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3